If you are looking to improve health outcomes and operational efficiency through the meaningful use of HIT, S&P can help.
It’s common to struggle with issues that surround MU3 as you’re creating a roadmap to consider technology upgrades (e.g. Cerner 2018) and meet key deadlines like e-prescribing (2020). How do you prioritize? Which vendors and investments will have the greatest chances of success, based on where you are now?
S&P has a long list of clients who we have helped leverage technology to improve their business performance and clinical outcomes. We help senior executives and HIT leaders develop a comprehensive roadmap—driven by corporate priorities—and imbued with effective governance. This roadmap is informed by industry knowledge and first-hand experience of both the operational and technical requirements to position our clients for meaningful adoption of healthcare information technology.
The result is a strategy that accounts for both current and future realities and provides for continual improvement and maximized return on investment.
If you are looking to develop a roadmap towards improved health outcomes and the meaningful use of HIT, S&P can help with: